Sep 11, 2026, 07:42 UTC
Tianyi Medical announced that Nikkiso's CRRT business has completed its transaction closing and will be integrated and incubated before being injected into the listed company at an opportune time.
Source:Aug 14, 2026, 06:00 UTC
Nikkiso Co., Ltd. reported its Q2 FY2026 results on August 14, 2026, with consolidated net profit for H1 (Jan-Jun) rising 67.5% year-on-year to 8.25 billion yen, reversing its previous forecast of a decline.
Source: